04Jan
14Nov
myBiometry Raises $5 Million in Oversubscribed Seed Round to Advance Next-Generation Asthma and COPD Care
Biometry Inc. (myBiometry), an asthma and COPD diagnostic and remote monitoring company, announced that it has successfully raised $5 million in an oversubscribed Seed funding round. The round was led by Dexcom Ventures, with participation from CareSource Indiana, Elevate Ventures, and other investor groups. This funding will advance the development of the company’s fenoTRACK solution, a breakthrough device designed to empower asthma and COPD patients by providing data to enable early detection of exacerbations. “We’re excited to partner with Dexcom...
10May
INVEST Pitch Perfect winner: myBiometry aims to prevent asthma attacks long before they happen
Nationwide, more than 25 million people have asthma, including about 20 million adults and 5.1 million children and adolescents. If not well-controlled, the chronic condition can cause airways to swell and narrow, making it hard to breathe. This is called an asthma attack, and in a single year, more than 10 million people have one, according to the Centers for Disease Control and Prevention, resulting in 1.6 million emergency room visits and over 3,500 deaths. Now a Boston-based startup, myBiometry, is...
05Apr